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ABSTRACT 
Photodynamic therapy (PDT) is a treatment modality that has advanced rapidly in recent years. It causes tissue and 
vascular damage with the interaction of a photosensitizing agent (PS), light of a proper wavelength, and molecular 
oxygen. Evaluation of vessel damage usually relies on histopathology evaluation. Results are often qualitative or at best 
semi-quantitative based on a subjective system. The aim of this study was to evaluate, using CD31 immunohistochem- 
istry and image analysis software, the vascular damage after PDT in a well-established rodent model of chemically in- 
duced mammary tumor. Fourteen Sprague-Dawley rats received a single dose of 7,12-dimethylbenz(a)anthraxcene (80 
mg/kg by gavage), treatment efficacy was evaluated by comparing the vascular density of tumors after treatment with 
Photogem® as a PS, intraperitoneally, followed by interstitial fiber optic lighting, from a diode laser, at 200 mW/cm and 
light dose of 100 J/cm directed against his tumor (7 animals), with a control group (6 animals, no PDT). The animals 
were euthanized 30 hours after the lighting and mammary tumors were removed and samples from each lesion were 
formalin-fixed. Immunostained blood vessels were quantified by Image Pro-Plus version 7.0. The control group had an 
average of 3368.6 ± 4027.1 pixels per picture and the treated group had an average of 779 ± 1242.6 pixels per area (P < 
0.01), indicating that PDT caused a significant decrease in vascular density of mammary tumors. The combined immu- 
nohistochemistry using CD31, with selection of representative areas by a trained pathology, followed by quantification 
of staining using Image Pro-Plus version 7.0 system was a practical and robust methodology for vessel damage evalua- 
tion, which probably could be used to assess other antiangiogenic treatments. 
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1. Introduction 
Photodynamic therapy (PDT) is a treatment modality 
with uses in oncology and cardiovascular disease [1]. 
The clinical treatment regimen consists of induction of 
cytotoxicity in proliferative cells through the interaction 
of a photosensitizing agent (PS), light of a proper wave- 
length, and molecular oxygen. Vascular and direct cell 
damages contribute to tumor destruction. The vessels are 
an important target for PDT using many photosensitizers 
[2]. With a derivative of hematoporphyrin as PS and 
large interval between the administration of PS and the 
lighting of the lesion, the action of PDT is more cellular, 
however if you use a shorter time interval the vascular 
response prevails [3]. 
Evaluation of vessel damage after antiangiogenic treat- 
ment in in vivo models usually relies on histopathology 
evaluation by a trained pathologist, which can be subjec- 
tive. Results are often qualitative or at best semiquantita- 
tive based on a subjective system. CD31 is a transmem- 
brane glycoprotein of the immunoglobin superfamily that 
plays an important role in cell-cell adhesion, it’s involved 
in angiogenesis, and it is a well-established marker for *Corresponding author. 
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endothelial cells. The aim of this study was to evaluate, 
using CD31 immunohistochemistry and image analysis 
software, the vascular damage after PDT in a well-estab- 
lished rodent model of chemically induced mammary tu- 
mor. 
2. Material and Methods 
2.1. Animals 
Thirteen young, nulliparous, Sprague-Dawley female rats 
were used in this study. The animals were fed with ap- 
propriate rat food in pellets, given filtered water, and 
kept under ideal conditions of temperature, humidity and 
light. 
2.2. Photosensitizer 
Photogem (Photogem, Moscow, Russia), a hematopor- 
phyrin derivative complex, was used as PS. A stock solu- 
tion of 5 mg/mL in 20 mM phosphate-buffered solution 
with 0.9% NaCl, pH 7.4 (PBS) was stored in the dark at 
4˚C. 
2.3. Light Source 
The light source used was the laser diode Ceralas 630® 
(Ceramoptec, Germany), which produces up to 2 W of 
optical power at a wavelength of 630 nm. The intensity 
applied was 200 mW/cm. 
2.4. Experimental Design 
Mammary tumors were induced by a single dose of 80 
mg/kg of 7,12-dimethylbenz(a)anthracene (DMBA, Sigma- 
Aldrich, St. Louis, MO) diluted in soybean oil given by 
gavage. After induction, the animals underwent daily via- 
bility inspection, and weekly physical examination, until 
tumor development. 
After that, the animals were divided into two groups: 
control group (6 animals, no PDT); and the treated group 
with Photogem® intraperitoneally, followed by interstitial 
fiber optic lighting 24 hours later, from a diode laser, at 
200 mW/cm and light dose of 100 J/cm directed against 
the tumor (7 animals). For this procedure, the animals 
were anesthetized with intramuscular injectioof xylazine 
2% (20 mg) and ketamine (50 mg) at the dosage of 0.2 
ml per 100 g of rat. 
Thirty hours after the PDT treatment, the animals were 
deeply anesthetized with isoflurane and then euthanized 
by transaction of the jugular veins. The lesions were ex- 
cised and analyzed by routine hematoxylin and eosin and 
immunohistochemistry. 
2.5. Immunohistochemistry 
The slides were placed for 30 minutes in the oven at 
65˚C after incubation in xylene (30 minutes), dipped in 
100% ethanol, then in 70% ethanol and rinsed in distilled 
water. Antigen retrieval was performed using Antigen 
Retrieval Buffer (Dako, Carpinteria, CA) in steamer for 
30 minutes. After this procedure, the slides were rinsed 
with distilled water. Blood vessels were identified using 
a rabbit polyclonal antibody against CD31 (PECAM-1, 
Biorbyt, San Francisco, CA). The detection system used 
was LSAB2 System-HRP for rat specimens (Dako, Car- 
pinteria, CA). The slides were stained with the reagent 
3,3'diaminobenzidine and counterstained with hematoxy- 
lin and eosin. 
2.6. Image Analysis 
Image Pro-Plus version 7.0 (Media Cybernetics, Rock- 
ville, MD) system was chosen for the image analysis 
because it allows a high degree of replication and auto- 
mation of image-processing steps and it is one of the 
most popular systems used currently by investigators. 
Pictures from three different areas of lowest vascular 
density of each tumor were submitted to the software for 
analysis. The colors correspondent to positive staining 
were recorded and numbers of pixels containing those 
colors per area were automatic counted on all pictures by 
the software, and interpreted as the vascular density of 
the lesion. 
2.7. Statistical Analysis 
To compare the vascular density in the two groups, sta- 
tistical analysis of the number of pixels correspondent to 
CD31 staining was done by Student’s t-test, using SAS 
version 9.2 (SAS Institute Inc, Cary, NC, USA). A value 
of P < 0.05 was considered to be statistically significant. 
3. Results and Discussion 
The analysis showed that the control group had an aver- 
age of 3368.6 ± 4027.1 pixels per picture (Figure 1) and 
the treated group had an average of 779 ± 1242.6 pixels 
(Figure 2) (P < 0.01), indicating that the PDT treatment 
induced a significant vascular damage. 
Angiogenesis has been long recognized as a key step 
in tumor growth and metastasis development [4]. By se- 
creting various growth factors, tumors induce blood ves- 
sel growth (angiogenesis), which allows tumor expansion 
[5]. Thus, angiogenesis is a necessary and required step 
for transition from a small harmless cluster of cells to a 
large tumor and is also required for the spread of a tumor, 
invasion and/or metastasis. To date, it has been demon- 
strated by innumerous works that tumors unable to suc- 
cessful induce angiogenesis will remain microscopic. 
The inhibition of angiogenesis is an attractive therapeutic 
approach to control tumor progression [6]. PDT mecha- 
nism of action is the local generation of cytotoxic singlet  
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Figure 1. CD31 immunostaining of control group. 50× im- 
mersion objective. 
 
 
Figure 2. CD31 immunostaining of treated group. 50× im- 
mersion objective. 
 
oxygen (1O2), which results in damage to tumor cells and 
stroma, especially the tumor vasculature, and usually is 
accompanied by an inflammatory response [7]. It was 
demonstrated that tumors treated with short drug light 
interval (DLI) PDT exhibited greater tumor regression 
compared to long DLI PDT, and that was attributed to a 
greater vascular damage in the tumor [8]. 
Microvessel density evaluation can be done in several 
different ways. Histopathology only is the most subjec- 
tive and prone to errors. Immunohistochemistry using 
antibodies against markers of vessels allows for more 
precise quantification of microvessels than by histology 
alone, but still relies on trained pathologists for interpre- 
tation and thus can be subjective. Available markers in- 
clude vWF, CD34, VEGF, and CD31. The latter is the 
most sensitive and specific for endothelial cells in paraf- 
fin sections [9-12]. The combined use of immunohisto- 
chemistry with selection of representative areas by a 
trained pathologist, and further quantification of positiv- 
ity by a software analysis may address some of the sub- 
jectivity of the other methods.  
In the present study, we demonstrated a significant de- 
crease in microvascular density induced by PDT in rat 
mammary tumor. Our results corroborate with several 
others studies that used PDT against different tumor mo- 
dels. For example, researchers found a significant de- 
crease in intensity of CD31-stained blood vessels in mu- 
rine colon carcinoma cells samples in PDT treated mice 
compared to non-treated controls [7]. Another study also 
showed evidence of vascular damage after PDT by CD31 
staining, in mice bearing colon-26 tumors. It was demon- 
strated that low dose PDT induces changes in vessel 
permeability. However, these changes were a subtle in- 
jury that was below the threshold needed to achieve tu- 
mor destruction. But with an increase of dosage, the 
treatment stimulates a catastrophic vascular collapse and 
dissolution, leading to tumor death [13]. Bhuvaneswari 
and collaborators [8] treated at a human bladder carci- 
noma xenograft model with long and short DLI PDT. At 
30 days after the treatment, they observed that although 
the short DLI PDT effect on the tumor had diminished 
and minimal staining was observed, comparably higher 
CD31-stained blood vessels were noticed in long DLI 
PDT, suggesting neovessel formation and tumor re- 
growth. Interestingly, they also observed upregulation of 
proangiogenic genes after PDT, which indicates a greater 
need for combination therapy by including antiangio- 
genic agents that target specific pathways. 
4. Conclusion 
Evaluation of the images shows that PDT causes a sig- 
nificant decrease in vascular density of mammary tumors, 
what is one of the advantages of this modality of treat- 
ment. The combined immunohistochemistry using CD31, 
with selection of representative areas by a trained pa- 
thology, followed by quantification of CD31 staining us- 
ing Image Pro-Plus version 7.0 system was a practical 
and robust methodology for vessel damage evaluation, 
that probably could be used to assess other antiangio- 
genic treatments. 
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